Moderna
MRNA
MRNA
912 hedge funds and large institutions have $29.1B invested in Moderna in 2022 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 300 increasing their positions, 353 reducing their positions, and 127 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% less capital invested
Capital invested by funds: $34.3B → $29.1B (-$5.25B)
17% less funds holding in top 10
Funds holding in top 10: 23 → 19 (-4)
37% less first-time investments, than exits
New positions opened: 80 | Existing positions closed: 127
Holders
912
Holding in Top 10
19
Calls
$4.77B
Puts
$1.81B
Top Buyers
| 1 | +$361M | |
| 2 | +$214M | |
| 3 | +$100M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$58.3M |
| 5 |
Amundi
Paris,
France
|
+$56.2M |
Top Sellers
| 1 | -$178M | |
| 2 | -$144M | |
| 3 | -$96.4M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$81.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$66.3M |